Cargando…
Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19
BACKGROUND: The effects of high-intensity immunity on coronavirus disease 2019 (COVID-19) remain unclear. Antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are preferentially induced in inpatients with COVID-19 compared with outpatients with milder disease, and immunosu...
Autores principales: | Yamaguchi, Tomoyuki, Shinagawa, Toshie, Kobata, Hisanobu, Nakagawa, Hidemitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278827/ https://www.ncbi.nlm.nih.gov/pubmed/34273512 http://dx.doi.org/10.1016/j.ijid.2021.07.015 |
Ejemplares similares
-
Fatal Pneumonia Associated With a Novel Genotype of Human Coronavirus OC43
por: Lau, Susanna Kar Pui, et al.
Publicado: (2022) -
Protein composition of coronavirus OC 43
por: Hierholzer, J.C., et al.
Publicado: (1972) -
The RNA of human coronavirus OC-43
por: Tannock, Gregory A., et al.
Publicado: (1977) -
Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host
por: Kasereka, Masumbuko C., et al.
Publicado: (2021) -
Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
por: Kistler, Kathryn E, et al.
Publicado: (2021)